ZNTL
Zentalis Pharmaceuticals Inc

683
Mkt Cap
$101.15M
Volume
257,230.00
52W High
$4.00
52W Low
$1.01
PE Ratio
-0.67
ZNTL Fundamentals
Price
$1.40
Prev Close
$1.40
Open
$1.41
50D MA
$1.49
Beta
1.58
Avg. Volume
614,550.58
EPS (Annual)
-$2.33
P/B
0.40
Rev/Employee
$406,174.70
Loading...
Loading...
News
all
press releases
Wall Street Zen Upgrades Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Hold
Wall Street Zen raised shares of Zentalis Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Sunday...
MarketBeat·19d ago
News Placeholder
More News
News Placeholder
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of "Hold" from Analysts
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Get Free Report) has been given an average recommendation of "Hold" by the eight analysts that are presently covering the company, MarketBeat.com...
MarketBeat·20d ago
News Placeholder
FY2025 Earnings Estimate for ZNTL Issued By HC Wainwright
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Stock analysts at HC Wainwright boosted their FY2025 EPS estimates for shares of Zentalis Pharmaceuticals in a note issued to investors on...
MarketBeat·21d ago
News Placeholder
Leerink Partnrs Has Positive Outlook of ZNTL FY2025 Earnings
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Research analysts at Leerink Partnrs upped their FY2025 earnings per share estimates for Zentalis Pharmaceuticals in a research report...
MarketBeat·21d ago
News Placeholder
Wedbush Expects Higher Earnings for Zentalis Pharmaceuticals
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Equities researchers at Wedbush boosted their FY2025 earnings per share estimates for Zentalis Pharmaceuticals in a research note issued...
MarketBeat·21d ago
News Placeholder
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Given New $4.00 Price Target at Morgan Stanley
Morgan Stanley decreased their price objective on shares of Zentalis Pharmaceuticals from $8.00 to $4.00 and set an "equal weight" rating on the stock in a report on Wednesday...
MarketBeat·22d ago
News Placeholder
Analysts Set Expectations for ZNTL Q1 Earnings
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Zentalis Pharmaceuticals in a report released on...
MarketBeat·22d ago
News Placeholder
What is Wedbush's Forecast for ZNTL Q1 Earnings?
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL - Free Report) - Equities researchers at Wedbush issued their Q1 2026 earnings estimates for Zentalis Pharmaceuticals in a research report issued to...
MarketBeat·22d ago
News Placeholder
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Earns "Neutral" Rating from Wedbush
Wedbush reaffirmed a "neutral" rating and set a $4.00 price target on shares of Zentalis Pharmaceuticals in a research note on Tuesday...
MarketBeat·23d ago
News Placeholder
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Releases Quarterly Earnings Results, Beats Expectations By $0.12 EPS
Zentalis Pharmaceuticals (NASDAQ:ZNTL - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.37) earnings per share for the quarter, beating the consensus estimate...
MarketBeat·24d ago

Latest ZNTL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.